Skip to content
Clinical Trials – home

Cimetidine: A Comprehensive Guide for Patients

1 / 2
trials open to patients / all trials
3+
Countries

In short

This article summarizes several clinical trials investigating the use of cimetidine, a histamine H2-receptor antagonist, in different medical contexts. These studies explore cimetidine's potential effects on bioequivalence, protoporphyrias, HIV infection, drug interactions, stress ulcer prophylaxis, atopic dermatitis, and kidney transplantation. The trials aim to evaluate cimetidine's efficacy, safety, and pharmacokinetic properties in various patient populations.

At a glance

Bioequivalence
Investigating the effects of excipients on cimetidine absorption in capsules and oral solutions
Protoporphyrias
Evaluating cimetidine's efficacy in reducing protoporphyrin levels and improving photosensitivity
HIV Infection
Assessing cimetidine's impact on CD4 lymphocyte counts in HIV-infected patients
Drug Interactions
Studying cimetidine's effects on the pharmacokinetics of other medications (e.g., imeglimin, lucerastat)
Stress Ulcer Prophylaxis
Comparing intravenous esomeprazole to cimetidine for preventing upper GI bleeding in seriously ill patients
Atopic Dermatitis
Investigating cimetidine's efficacy in reducing atopic dermatitis severity and modulating immune responses
Kidney Transplantation
Evaluating the performance of cimetidine-corrected MDRD equation in estimating GFR in renal transplant patients

What is Cimetidine?

Cimetidine is a medication that belongs to a class of drugs called H2 receptor antagonists, also known as H2 blockers. It is commonly sold under the brand name Tagamet. Cimetidine has been widely used for many years, primarily to treat conditions related to excess stomach acid.

Uses of Cimetidine

Cimetidine is used to treat various conditions, including:

  • Stress Ulcer Prophylaxis: It helps prevent stress-related upper gastrointestinal (GI) bleeding in seriously ill patients.
  • Gastroesophageal Reflux Disease (GERD): Cimetidine can help reduce stomach acid, alleviating symptoms of GERD.
  • Peptic Ulcers: It aids in the treatment and prevention of stomach and duodenal ulcers.
  • Atopic Dermatitis: Some studies have explored its potential in treating acute extrinsic atopic dermatitis, a type of eczema.

How Cimetidine Works

Cimetidine works by blocking histamine receptors in the stomach. Specifically, it targets H2 receptors, which are responsible for stimulating acid production. By blocking these receptors, cimetidine reduces the amount of acid produced by the stomach.

In addition to its effects on stomach acid, cimetidine has been found to have some immunomodulatory properties. This means it can affect the immune system. In the context of atopic dermatitis, it may help by:

  • Activating Th1 cells (a type of immune cell)
  • Lowering Th2 cell activity
  • Reducing levels of Immunoglobulin E (IgE), an antibody associated with allergic reactions

Cimetidine in Clinical Trials

Cimetidine has been the subject of numerous clinical trials exploring its various uses and effects:

  • Stress Ulcer Prevention: A study compared intravenous cimetidine to esomeprazole for preventing stress-related upper GI bleeding in seriously ill patients.
  • Atopic Dermatitis: Research has investigated cimetidine's potential in treating acute extrinsic atopic dermatitis, measuring its effects on various immune markers and disease severity.
  • HIV Treatment: A study explored cimetidine's effect on CD4 lymphocyte counts in HIV-infected patients.
  • Drug Interactions: Several trials have examined how cimetidine interacts with other medications, such as imeglimin and lucerastat.
  • Renal Function: Research has looked at how cimetidine affects the accuracy of tests measuring kidney function in transplant patients.

Side Effects and Safety

While cimetidine is generally considered safe, like all medications, it can cause side effects. Common side effects may include:

  • Headache
  • Dizziness
  • Diarrhea or constipation
  • Muscle pain
  • Rash

It's important to note that the safety and side effect profile can vary depending on the dosage, route of administration (oral or intravenous), and individual patient factors.

Special Considerations

There are several special considerations to keep in mind when using cimetidine:

  • Drug Interactions: Cimetidine can interact with various medications. It may affect how other drugs are processed in the body, potentially increasing or decreasing their effectiveness.
  • Kidney Function: Cimetidine can affect certain tests used to measure kidney function. This is important for doctors to consider when interpreting test results, especially in kidney transplant patients.
  • Breastfeeding: Cimetidine can be excreted in breast milk. Studies are ongoing to better understand how this might affect infants and how the excretion changes over time postpartum.

Always consult with your healthcare provider before starting or stopping any medication, including cimetidine. They can provide personalized advice based on your specific health situation and any other medications you may be taking.

Questions people often ask

Conditions where Cimetidine is being studied

Each condition opens its own overview and trial list

Trials with Cimetidine

Recruiting trials first

See all 2 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).